Unimed Biotech (Shanghai) Co., Ltd. is a high-tech enterprise that focuses on the field of reproductive genetics and prenatal diagnosis, and independently develops single cell separation and detection technology. The current projects include: preimplantation genetic diagnosis (PGD), PGT-A, cb-NIPT single cell noninvasive prenatal genetic testing, whole genome SNP array, prenatal amniotic fluid testing, carrier screening, abortion tissue genetic analysis, molecular screening of fragile X syndrome, etc.

Shanghai Genesky clinical laboratory is a clinic institution approved by Shanghai Municipal Health and Family Planning Commission in December 2016.The main business of Shanghai Tianhao medical laboratory includes genetic disease screening and diagnosis, newborn birth defect screening, prenatal screening and diagnosis, peraonalized treatment and cancer risk prediction. These can not only strengthen the existing business of Unimed, but also expand the  business territory of Unimed.Through the acquisition of Shanghai Tianhao Clinical laboratory, Unimed has established its own independent third-party clinical testing center, aiming to strengthen its clinical diagnosis territory and enhance its service quality.